Adjuvant Elicited T Cell Responses for Therapeutic Intervention

Explore a 34-minute webinar on adjuvant-elicited T cell responses for therapeutic intervention, presented by Dr. Ross Kedl, an expert in vaccine adjuvants and technology. Delve into the challenges of developing effective therapeutic vaccines for chronic diseases and cancer, focusing on the importance of cellular immunity. Learn about the limitations of current prophylactic vaccines that primarily target humoral immunity, and discover new approaches to adjuvant design and delivery for enhancing vaccine-elicited cellular responses. Gain insights into the role of T cells in successful cancer therapies and the potential for vaccines to generate sufficient T cell frequencies. Understand how this research could revolutionize therapeutic interventions for various diseases. Earn PACE credits by watching the webinar and following the provided instructions.

Adjuvant Elicited T Cell Responses for Therapeutic Intervention